Unity Biotechnology

Unity Biotechnology is a biopharmaceutical company focused on developing therapies to slow or reverse aging-related diseases by targeting and eliminating senescent cells—cells that have stopped dividing and contribute to tissue damage and inflammation. Their goal is to improve healthspan, the period of life spent in good health, by addressing the root causes of aging-related decline. Using advanced drug technologies, Unity aims to develop treatments for conditions like osteoarthritis, eye diseases, and neurodegeneration, ultimately helping people age more healthily and reducing age-associated health issues.